Centile Bioscience Inc.
Other Technology · BETHESDA, MD
Other TechnologySEC Form D
Centile Bioscience Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 16, 2026, reporting $3,054,996 raised toward a $4,054,996 offering.
Incorporated in Delaware and based in BETHESDA, MD, it operates in the Other Technology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Centile Bioscience Inc. has raised capital from private investors.
Browse more recently funded companies in Other Technology.
Executives & Directors
- Jakob SeidlitzExecutive Officer · Director
- Richard BethlehemExecutive Officer
- Joshua BernstockExecutive Officer · Director
- L. Keith MullinsDirector
- Hannah MamuszkaDirector
Recently funded in Other Technology
Other companies that recently filed a Form D
$25.0KRaised
Bluera Inc.
$100.0KRaised
Weston AI, Inc.
$1.0MRaised
SitePulse AI Inc
$517.0Raised
Voyadoc Inc.
$14.5KRaised